Clinical Trial Update: Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on preventing contrast-induced nephropathy with sodium bicarbonate; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Universidad de Antioquia | Conditions: Acute Kidney Failure | Phase 2, Phase 3 | Status: COMPLETED